FDA 510(k)

LAS-R HUMAN ANTITHROMBIN III TEST

K-Number: K772328 · 1978-02-03

ApplicantHyland Therapeutic Div., Travenol Laboratories

Decision Date1978-02-03

Product CodeJBQ

Advisory CommitteeHE

DecisionSubstantially Equivalent

Device Summary

LAS-R HUMAN ANTITHROMBIN III TEST is the device name listed in this FDA 510(k) record. The listed applicant is Hyland Therapeutic Div., Travenol Laboratories. It received FDA 510(k) clearance on 1978-02-03 under 510(k) number K772328. The device is classified under product code JBQ. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LAS-R HUMAN ANTITHROMBIN III TEST?

LAS-R HUMAN ANTITHROMBIN III TEST is a medical device that received FDA 510(k) clearance on 1978-02-03. The listed applicant is Hyland Therapeutic Div., Travenol Laboratories. The 510(k) number is K772328.

When did LAS-R HUMAN ANTITHROMBIN III TEST receive FDA 510(k) clearance?

LAS-R HUMAN ANTITHROMBIN III TEST received FDA 510(k) clearance on 1978-02-03, under 510(k) number K772328.

Who is the listed applicant for LAS-R HUMAN ANTITHROMBIN III TEST?

The FDA 510(k) record lists Hyland Therapeutic Div., Travenol Laboratories as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LAS-R HUMAN ANTITHROMBIN III TEST?

The FDA product code for LAS-R HUMAN ANTITHROMBIN III TEST is JBQ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Hyland Therapeutic Div., Travenol Laboratories as applicant

K820835ALUMINA SILICA-ACTIVATED PARTIAL THROM K820192HAEMOPHILUS INFLUENZAE TYPE B ANTISERUM K812220NEPHELOMETRIC SOLID TURBIDITY STANDARD K810078Q-PAK THERAPEUTIC DRUG MONIT. CONTROL S K810077OMEGA THERAPEUTIC DRUG MONIT. CONTROL S.K802610ALERT A,HDL-APOLIPOROTEIN A, TEST KIT

View all 44 devices →

Related Devices (Code: JBQ)

K242952INNOVANCE AntithrombinSiemens Healthcare Diagnostic Products GmbH K081769INNOVANCE ANTITHROMBIN WITH MODELS OPFH03, OPFHO5Siemens Healthcare Diagnostics K070301HEMOSIL ANTITHROMBINInstrumentation Laboratory CO K062431HEMOSIL LIQUID ANTITHROMBINInstrumentation Laboratory CO K043007BIOPHEN ANTITHROMBIN 2.5, REFERENCE # 221102; BIOPHEN ANTITHROMBIN 5, REFERENCE # 221105Hyphen Biomed K033775HEMOSIL LIQUID ANTITHROMBIN XLInstrumentation Laboratory CO

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.